
Episode #57
Revolutionary new implant for dry age-related macular degeneration
<p>Send us your feedback</p><p>With over 84% of trial participants regaining the ability to read letters, numbers, and words. Mahi Muqit, senior vitreoretinal consultant at Moorfields Eye Hospital and the Institute of Ophthalmology at UCL, joins us to discuss the groundbreaking results from the PRIMA system clinical trial. Learn how the technology works and what this means for the future of treating patients with dry AMD and geographic atrophy.</p><p>If you would like to join the Macular Society's Research Participant Database, visit our website and sign up. </p><p>To watch our previous webinars, please visit o...

